Quthero secures $500,000 investment boost from the Ontario Centre of Innovation

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, recently announced the successful acquisition of $500,000 in investment funding from the Ontario Centre of Innovation's (OCI) Life Science Innovation Fund. This is in addition to a co-investment of $850,000 for a total round size of $1,350,000.

Quthero is an OBIO® member, an alumnus of our BDSP™, CAAP®, HealthMINT™ programs, and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Tenomix secures oversubscribed $2.1M, all-Canadian financing round to advance cancer staging
Next

Noa Therapeutics secures pre-Seed financing to transform the treatment of inflammatory disease